Clinical Trials Logo

Filter by:
NCT ID: NCT05170113 Completed - Fatigue Clinical Trials

Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health

Start date: November 2, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effectiveness and safety of the Alpinia galanga formulation, Theacrine formulation, and Caffeine formulation on fatigue, mental acuity, and cognitive health among overall healthy participants

NCT ID: NCT05170061 Completed - Hypertension Clinical Trials

24 Hour Ambulatory Cardiac Oxygen Consumption

Start date: February 2013
Phase: Phase 3
Study type: Interventional

A randomized,double-blind,double-dummy,active controlled,15 week study to evaluate the effects of nebivolol and valsartan alone and in combination on 24-hour ambulatory cardiac work and variability of heart rate-mean central systolic pressure product.

NCT ID: NCT05169905 Completed - Clinical trials for Respiratory Syncytial Virus Infections

A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age

Start date: February 2, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate the reactogenicity, safety and immune response of a single intramuscular dose of the respiratory syncytial virus maternal (RSV MAT) vaccine in healthy non-pregnant girls 9-17 years of age (YOA) compared to non-pregnant adult women 18-49 YOA. The combined reduced-antigen-content diphtheria, tetanus and acellular pertussis (dTpa) vaccine was planned to be used as an active control for safety and reactogenicity evaluation. Following a recommendation from the Independent Data Monitoring Committee of NCT04605159 (RSV MAT 009), GSK made the decision to stop enrolment and vaccination in this study. Enrolled study participants were monitored as part of the study until study completion.

NCT ID: NCT05169684 Completed - Clinical trials for Prostatic Neoplasms, Castration-Resistant

A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Start date: February 14, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety, efficacy, tolerability, and toxicity of docetaxel alone, in combination with BMS-986218, or in combination with nivolumab plus BMS-986218 in men who have metastatic castration-resistant prostate cancer (mCRPC) that progressed after novel antiandrogen therapy and have not received chemotherapy for mCRPC.

NCT ID: NCT05169671 Completed - Healthy Volunteers Clinical Trials

Safety, Tolerability, and Pharmacokinetics Study of ATH-1020

Start date: March 30, 2022
Phase: Phase 1
Study type: Interventional

This Phase 1 randomized, placebo-controlled, double-blinded, first-in-human study will evaluate safety, tolerability, and pharmacokinetics of single and multiple ascending doses of ATH-1020 in healthy young and elderly subjects.

NCT ID: NCT05169424 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)

Start date: December 17, 2021
Phase:
Study type: Observational

This study looks at data from people with chronic obstructive pulmonary disease (COPD). Some used Stiolto Respimat and the others Trelegy Ellipta as their first treatment for COPD. The purpose of this study is to find out how well the treatments worked. Researchers compare the time to first COPD flare-up (exacerbation) between the 2 treatments. The study analyses anonymous data from pharmacy claims collected over 3.5 years.

NCT ID: NCT05169281 Completed - Surgery Clinical Trials

Distribution of Medication Disposal Packets - Acute Opioid Prescribing

Start date: March 24, 2021
Phase: N/A
Study type: Interventional

Many prescription opioids following surgery are left unused and are at risk of being misused or diverted. Encouraging proper disposal is important, yet motivating this behavior remains challenging as patients must understand the risks of opioids, the benefits of disposal, and identify opportunities and places to dispose of them safely. Alternative disposal techniques can improve disposal rates but may be lost or forgotten. Applying behavioral economics techniques may lower the barriers and promote disposal. The objective is to test the effect of a specifically timed, mailed, at-home kit on disposal rates following surgery.

NCT ID: NCT05168800 Completed - COVID-19 Clinical Trials

CONFIDENT: Supporting Long-term Care Workers During COVID-19

Start date: February 21, 2022
Phase: N/A
Study type: Interventional

The CONFIDENT Study is an online three-arm randomized trial that aims to help long-term care workers in the United States feel more confident about the Coronavirus Disease 2019 (COVID-19) vaccines. The study will compare two different interventions to usual online information (website of the Centers for Disease Control and Prevention). The first intervention is a Dialogue-Based Webinar where people can interact and ask questions about the vaccines. The second intervention is a Social Media Website that will feature curated content about the vaccines from popular social media platforms. Participants will be asked to completed four online surveys. The first survey will be completed pre-intervention and immediately upon study enrollment (Time 0). Participants will be randomized to a trial arm at the end of the Time 0 survey. Intervention follow-up surveys will be completed 3 weeks post-randomization (Time 1), three months post-randomization (Time 2), and 6 months post-randomization (Time 3).

NCT ID: NCT05168735 Completed - Clinical trials for Depression, Unipolar

Ketamine + Mindfulness for Depression

Start date: February 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

In this project, the investigators will administer a single infusion of IV ketamine to depressed patients and randomize the patients to receive either a) usual/typical infusion conditions or b) mindfulness training and exercises in conjunction with the infusion. Investigators will test whether the conjunction of ketamine + mindfulness enhances the reductions in depression following a single ketamine infusion.

NCT ID: NCT05168670 Completed - Dry Eye Disease Clinical Trials

Safety of Tinted Soft Scleral Eye Shields When IPL is Applied on Eyelids

Start date: December 21, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to verify the safety of tinted soft scleral eye shields when IPL is applied directly on eyelids.